Monthly Archives: August 2019

Dipeptidyl Peptidase 3 (DPP3) cause of acute myocardial depression. sphingotec launches first IVD test for DPP3 on Nexus IB10 Point-of-Care platform

sphingotec launched the very first CE-marked IVD assay for Dipeptidyl Peptidase 3 (DPP3), a novel biomarker able to assess outcomes in patients with cardiogenic shock at admission for further clinical validation through the critical care community IB10 sphingotest® DPP3 is now available on sphingotec’s proprietary automated Nexus IB10 point-of-care platform and quantitatively measures levels of…
Read more